Paper33301643
Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
Li Y and 6 others. FEBS Open Bio, 2021. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers. Papers, record 33301643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33301643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Breast Neoplasms, Male | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| N-Acetylgalactosaminyltransferases | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Apoptosis | |
| Cell Movement | |
| Cell Proliferation | |
| Disease-Free Survival | |
| Epithelial-Mesenchymal Transition | |
| Female | |
| Gene Knockdown Techniques | |
| Humans | |
| MCF-7 Cells | |
| Male | |
| Matrix Metalloproteinase 2 | |
| Middle Aged | |
| Neoplasm Invasiveness | |
| Neoplasm Staging | |
| Peptides | |
| Prognosis |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28407145 | GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28407145 | PubMed |
| 2 | 32612115 | Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32612115 | PubMed |
| 3 | 19531263 | Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature. | BMC Cancer | 2009 | https://conductscience.org/library/papers/19531263 | PubMed |
| 4 | 18316376 | Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18316376 | PubMed |
| 5 | 27840993 | NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers. | Oncol Rep | 2017 | https://conductscience.org/library/papers/27840993 | PubMed |
| 6 | 30826152 | CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway. | Pathol Res Pract | 2019 | https://conductscience.org/library/papers/30826152 | PubMed |
| 7 | 25979173 | The relevance of EMT in breast cancer metastasis: Correlation or causality? | FEBS Lett | 2015 | https://conductscience.org/library/papers/25979173 | PubMed |
| 8 | 19910308 | edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. | Bioinformatics | 2010 | https://conductscience.org/library/papers/19910308 | PubMed |
| 9 | 163683 | The glycosaminoglycans in human hepatic cancer. | Cancer Res | 1975 | https://conductscience.org/library/papers/163683 | PubMed |
| 10 | 32348423 | Expression of CHPF modulates cell proliferation and invasion in lung cancer. | Braz J Med Biol Res | 2020 | https://conductscience.org/library/papers/32348423 | PubMed |
| 11 | 12716890 | Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12716890 | PubMed |
| 12 | 22912547 | Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/22912547 | PubMed |
| 13 | 31639340 | Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1. | Eur J Pharmacol | 2019 | https://conductscience.org/library/papers/31639340 | PubMed |
| 14 | 28627702 | Lentivirus‑mediated knockdown of chondroitin polymerizing factor inhibits glioma cell growth in vitro. | Oncol Rep | 2017 | https://conductscience.org/library/papers/28627702 | PubMed |
| 15 | 28608941 | TGF-β Stimulates Expression of Chondroitin Polymerizing Factor in Nucleus Pulposus Cells Through the Smad3, RhoA/ROCK1, and MAPK Signaling Pathways. | J Cell Biochem | 2018 | https://conductscience.org/library/papers/28608941 | PubMed |
| 16 | 28260181 | Breast cancer in young women: an overview. | Updates Surg | 2017 | https://conductscience.org/library/papers/28260181 | PubMed |
| 17 | 20440544 | Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. | J Mammary Gland Biol Neoplasia | 2010 | https://conductscience.org/library/papers/20440544 | PubMed |
| 18 | 25126564 | Human genetic disorders and knockout mice deficient in glycosaminoglycan. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25126564 | PubMed |
| 19 | 24740185 | Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients. | Int J Cancer | 2014 | https://conductscience.org/library/papers/24740185 | PubMed |
| 20 | 20929582 | The chondroitin/dermatan sulfate synthesizing and modifying enzymes in laryngeal cancer: expressional and epigenetic studies. | Head Neck Oncol | 2010 | https://conductscience.org/library/papers/20929582 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41298522 | Structural basis for human chondroitin sulfate chain polymerization. | Nat Commun | 2025 | https://conductscience.org/library/papers/41298522 | PubMed |
| 38770553 | Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression. | Mol Oncol | 2024 | https://conductscience.org/library/papers/38770553 | PubMed |
| 37851364 | The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37851364 | PubMed |
| 36277284 | Characterization of glucose metabolism in breast cancer to guide clinical therapy. | Front Surg | 2022 | https://conductscience.org/library/papers/36277284 | PubMed |
| 36042157 | Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-β1/SMAD3 and JNK axis activation. | J Cell Commun Signal | 2023 | https://conductscience.org/library/papers/36042157 | PubMed |
| 35372047 | Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35372047 | PubMed |
| 34511983 | Four Immune-Related Genes (FN1, UGCG, CHPF2 and THBS2) as Potential Diagnostic and Prognostic Biomarkers for Carbon Nanotube-Induced Mesothelioma. | Int J Gen Med | 2021 | https://conductscience.org/library/papers/34511983 | PubMed |
| 34195087 | A Novel Prognostic Signature Based on Metabolism-Related Genes to Predict Survival and Guide Personalized Treatment for Head and Neck Squamous Carcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/34195087 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| CHPF | 79586 | PubTator's text mining | https://conductscience.org/library/genes/79586 | NCBI Gene |
| CHPF2 | 54480 | PubTator's text mining | https://conductscience.org/library/genes/54480 | NCBI Gene |
| CS | 1431 | PubTator's text mining | https://conductscience.org/library/genes/1431 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| SNAI1 | 6615 | PubTator's text mining | https://conductscience.org/library/genes/6615 | NCBI Gene |
| SNAI2 | 6591 | PubTator's text mining | https://conductscience.org/library/genes/6591 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33301643
GET https://conductscience.org/api/papers/v1/33301643/references?page=2